Top news of the week: 09.06.2020.

#biotechnology #biospace #lifesciences #pharmaceuticals #lifescience #marketing #CoronaOutbreak #COVID19 #CoronaPandemic #CoronaVirus

Career And Jobs

On Jun 8, 2020
@BioWorld shared
Conducting the business of biotech during a pandemic https://t.co/7HWQdvkA7p
Open

Conducting the business of biotech during a pandemic

Conducting the business of biotech during a pandemic

When BIO 2019 closed its doors in Philadelphia last June, none of the delegates of the industry’s largest event would have predicted that the next meeting, scheduled for San Diego, would be ...

On Jun 4, 2020
@Labiotech_eu shared
As #lifescience professionals, we handle hard science and research everyday. But we're also confronted with business-related tasks, such as starting conversations with our audiences. Here is a guide to help you level up your life science #marketing skills! https://t.co/e9Fj8C2jkP
Open

The Beginner’s Guide to Biotech & Life Science Marketing

The Beginner’s Guide to Biotech & Life Science Marketing

As life science professionals, we not only continuously handle hard science and research, but we also have to learn how to market our products and interact with a large online audience. ...

On Jun 5, 2020
@biospace shared
How COVID-19 is Affecting Clinical Trials and Drug Supplies from Biotech Bay Companies #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/xGg3h8rJrP
Open

How COVID-19 is Affecting Clinical Trials and Drug Supplies from Biotech Bay Companies

How COVID-19 is Affecting Clinical Trials and Drug Supplies from Biotech Bay Companies

Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.

On Jun 2, 2020
@JohnCendpts shared
Pfizer’s Doug Giordano has $500M — and some advice — to offer a certain breed of 'breakthrough' biotech $PFE https://t.co/0Cps7alxNY
Open

Pfizer’s Doug Giordano has $500M — and some advice — to offer a certain breed of 'breakthrough' biotech

Pfizer’s Doug Giordano has $500M — and some advice — to offer a certain breed of 'breakthrough' biotech

So let’s say you’re running a cutting-edge, clinical-stage biotech, probably public, but not necessarily so, which could see some big advantages teaming up with some marquee researchers, ...

On Jun 5, 2020
@biospace shared
Investment Group Atlas Venture Closes $400 Million Fund for Biotech Startups #biospace #lifesciences #biotechnology #pharmaceuticals https://t.co/4mWUNE5Gcf
Open

Investment Group Atlas Venture Closes $400 Million Fund for Biotech Startups

Investment Group Atlas Venture Closes $400 Million Fund for Biotech Startups

With the close of the fund, Atlas Venture said it will continue to advance its mission of “doing well by doing good” and building biotech companies that will deliver high-impact therapies ...

On Jun 2, 2020
@JohnCendpts shared
Once a high flyer, a staggering Aduro is auctioning off most of the pipeline as CEO Stephen Isaacs hands off the shell to new owners $ADRO soon $KDNY https://t.co/XfDcobFNie
Open

Once a high flyer, a staggering Aduro is auctioning off most of the pipeline as CEO Stephen Isaacs hands off the shell to new owners

Once a high flyer, a staggering Aduro is auctioning off most of the pipeline as CEO Stephen Isaacs hands off the shell to new owners

After a drumbeat of failure, setbacks and reorganizations over the last few years, Aduro CEO Stephen Isaacs is handing over his largely gutted-out shell of a public company to another ...

On Jun 4, 2020
@JohnCendpts shared
Amgen vet David Meline finds a new CFO roost at Moderna, taking a ride on the Covid-19 tiger as departing exec cashes out with $12M $AMGN $MRNA https://t.co/Eb2OToPHaZ
Open

Amgen vet David Meline finds a new CFO roost at Moderna, taking a ride on the Covid-19 tiger as departing exec cashes out with $12M

Amgen vet David Meline finds a new CFO roost at Moderna, taking a ride on the Covid-19 tiger as departing exec cashes out with $12M

We found out a few weeks ago that Moderna CFO Lorence Kim isn’t waiting around to see how the biotech wunderkind makes out in its frantic race to field a messenger RNA vaccine that can ...

On Jun 3, 2020
@FiercePharma shared
Biopharma CEOs call for action on systemic racism—across America and in their own ranks https://t.co/6NGBTnQqMP
Open

Biopharma CEOs call for action on systemic racism—across America and in their own ranks

Biopharma CEOs call for action on systemic racism—across America and in their own ranks

After the deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, Americans have taken to the streets to call out racial inequalities, police violence and systemic racism. Biopharma CEOs ...